Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-051 - Nivolumab Versus Chemotherapy as Post-Platinum Therapy for Advanced Non-Small Cell Lung Cancer in a Real-world Setting
09:30 - 09:30 | Presenter: Edward Brian Garon | Author(s): M. Moezi, J. Chandler, D. Waterhouse, S. Wilks, D. Richards, M. Hussein, David R Spigel, V. Gunuganti, M.D. Danese, M. Gleeson, D. Lubeck, V. Burns, B. Korytowsky, C. Batenchuk, R. Jotte
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-014 - ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients with NSCLC and ECOG PS 2
09:00 - 09:00 | Presenter: Ajeet Gajra | Author(s): N. Abdel Karim, D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel
- Abstract
Loading... -
+
P2.01-015 - Longitudinal Assessment of Performance Status (PS) in Patients with NSCLC and ECOG PS 2 on Nab-Paclitaxel–Based Therapy
09:00 - 09:00 | Presenter: Nagla Abdel Karim | Author(s): D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel, Ajeet Gajra
- Abstract
Loading...
-
+
MA 10 - Immunotherapy I
- 11:00 - 12:30
- 10/17/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:S. Wang, Robert Pirker
-
+
MA 10.05 - Improved Outcome for Immune Checkpoint Inhibitors (ICI) in Patients Previously Treated with Bavituximab in the SUNRISE Trial
11:30 - 11:35 | Presenter: Michael Boyer | Author(s): David R Spigel, P. Mainwaring, H. Lena, M. McCleod, G. Losonczy, R.E. Sanborn, R. Natale, M. Tang, J. Lai, N.L. Kallinteris, Joseph Shan, David E Gerber
- Abstract
Loading...
-
+
P3.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P3.07-012 - Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
09:30 - 09:30 | Presenter: Lucio Crinò | Author(s): L. Horn, Enriqueta Felip, O. Arén Frontera, M.A. Burgio, D. Waterhouse, G. Blumenschein, Fabrice Barlesi, Marina Chiara Garassino, E. Holgado, S. Antonia, David R Spigel, Justin F Gainor, Scott N. Gettinger, W.J. Geese, A. Li, D. Healey, Neal Ready
- Abstract
Loading...
-
+
P3.08 - Locally Advanced Nsclc
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P3.08-004 - Phase I/II Trial of Nab-Paclitaxel or Paclitaxel Plus Carboplatin with Concurrent Radiation for Inoperable Stage IIIA/B NSCLC
09:30 - 09:30 | Presenter: Aaron Laine | Author(s): P. Iyengar, K.D. Westover, A. Christie, I. Smith, S. Shakeel, A. Attia, L.C. Villaruz, David E Gerber, Y. Chen, David R Spigel, M.A. Socinski, Hak Choy
- Abstract
Loading...